Melanoma drug side effects on eyes revealed in new study

NCT ID NCT07431489

First seen Feb 28, 2026 · Last updated May 13, 2026 · Updated 12 times

Summary

This study looked at 30 people with melanoma who were taking BRAF/MEK inhibitor drugs. The goal was to see how often these drugs cause retinal changes (MEKAR) and what those changes look like. Participants had regular eye exams before, during, and after treatment to track any vision problems.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT MELANOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Institute of Oncology Ljubljana

    Ljubljana, 1000, Slovenia

Conditions

Explore the condition pages connected to this study.